PAPA JOSEPH C
SEC insider (Form 3/4/5 filer). CIK 0001242215. Director at Candel Therapeutics, Inc. (CADL) and 2 other issuers. 17 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in NEEDHAM, MA.
Companies PAPA JOSEPH C has filed insider reports for
- Candel Therapeutics, Inc. (CADL): Director
- Milestone Pharmaceuticals Inc. (MIST): Director
- Emergent BioSolutions Inc. (EBS): Director, Officer, President and CEO
PAPA JOSEPH C
CIK: 0001242215
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Sep 30, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
1.3K shares at avg. $8.68- - Jun 30, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
1.3K shares at avg. $8.64- - Jun 23, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
32K shares- - Jun 10, 2026MIST
Milestone Pharmaceuticals Inc.
AwardDirectStock Option (right to buy)
77K shares- - Apr 29, 2026EBS
Emergent BioSolutions Inc.
AwardDirect187.7K shares- - Mar 31, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
2.8K shares at avg. $4.11- - Mar 5, 2026EBS
Emergent BioSolutions Inc.
Tax PaymentDirect37.1K shares at avg. $8.44$313K - Mar 3, 2026EBS
Emergent BioSolutions Inc.
AwardDirectEmployee Stock Option (Right to buy)
252.2K shares- - Jul 11, 2025MIST
Milestone Pharmaceuticals Inc.
AwardDirect100K shares- - Jun 25, 2025CADL
Candel Therapeutics, Inc.
AwardIndirect64.2K shares at avg. $4.67$300K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 |  CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 1,325 | $8.68 | - | Direct |
| Jun 30, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 1,331 | $8.64 | - | Direct |
| Jun 23, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 32,000 | - | - | Direct |
| Jun 10, 2026 |  MIST Milestone Pharmaceuticals Inc. | Award Stock Option (right to buy) | 77,000 | - | - | Direct |
| Apr 29, 2026 |  EBS Emergent BioSolutions Inc. | Award | 187,708 | - | $0 | Direct |
| Mar 31, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 2,795 | $4.11 | - | Direct |
| Mar 5, 2026 | EBS Emergent BioSolutions Inc. | Tax Payment | 37,055 | $8.44 | $312,744 | Direct |
| Mar 3, 2026 | EBS Emergent BioSolutions Inc. | Award Employee Stock Option (Right to buy) | 252,194 | - | - | Direct |
| Jul 11, 2025 | MIST Milestone Pharmaceuticals Inc. | Award | 100,000 | - | - | Direct |
| Jun 25, 2025 | CADL Candel Therapeutics, Inc. | Award | 64,239 | $4.67 | $299,996 | Indirect |
1-10 of 17 transactions